Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Unmasking the Myths: Debunking Top Misconceptions About Snakes


News provided by

Asclepius Snakebite Foundation

Apr 18, 2024, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Snakes, such as rattlesnakes, play a vital role in the ecosystem.
Snakes, such as rattlesnakes, play a vital role in the ecosystem.

Asclepius Snakebite Foundation Leads the Charge in Clarifying Misunderstandings and Promoting Snakebite Awareness

AURORA, Colo., April 18, 2024 /PRNewswire-PRWeb/ -- As March and April mark the onset of snake season in the United States, the Asclepius Snakebite Foundation is stepping forward to address common misconceptions surrounding snakes and snakebite treatment. As an international coalition of physicians, paramedics, and scientists committed to combating the devastating impact of snakebites in the developing world, the Asclepius Snakebite Foundation aims to demystify snakebites and empower communities to take proactive measures.

"It's crucial to dispel myths surrounding snakes and snakebites. Misinformation can exacerbate the risks and hinder appropriate treatment, leading to dire consequences," said Dr. Nick Brandehoff, Executive Director of the Asclepius Snakebite Foundation. "Through education and awareness, we can save lives."

"It's crucial to dispel myths surrounding snakes and snakebites. Misinformation can exacerbate the risks and hinder appropriate treatment, leading to dire consequences," said Dr. Nick Brandehoff, Executive Director of the Asclepius Snakebite Foundation.

Post this

Misconceptions:
1.    Buying and Using Snakebite Kits: Contrary to popular belief, snakebite kits are not recommended for treating snakebites. The correct approach involves staying calm, calling 911, keeping the injured part elevated at or above the level of the heart, removing any constrictive clothing, marking around the bite area, refraining from taking medications, and noting the time of the incident.
2.    Taking Benadryl after a Snakebite: Taking Benadryl or other antihistamines after a snakebite does not provide effective treatment. Relying on these medications can create a false sense of security and delay seeking proper medical care.
3.    Killing Snakes if Seen: Snakes play a vital role in the ecosystem, and indiscriminate killing can disrupt the delicate balance of nature. It's important to exercise caution and avoid harming snakes unnecessarily.
4.    Snakes Are Aggressive and Chase Humans: Contrary to popular belief, snakes do not chase humans. Most snake encounters occur when humans inadvertently intrude upon their habitat. Understanding snake behavior can help prevent unnecessary panic and confrontation.
5.    All Snakes Are Venomous: In the United States, only a small fraction of snake species are venomous, with the majority being non-venomous and harmless to humans. Understanding the distinguishing features of venomous snakes and practicing caution in areas where snakes are prevalent can significantly reduce the likelihood of snakebites. With just 3-5 deaths attributed to snakebites annually in the US and approximately 9,000 bites reported each year, awareness and preparedness are essential in mitigating the risks associated with encounters with these creatures.
6.    Antivenoms Are Not Safe: In the United States, antivenoms are safe and effective treatments for snakebites. Prompt administration of antivenom under medical supervision can significantly improve outcomes for snakebite victims.

The Asclepius Snakebite Foundation urges individuals and communities to support efforts in combating snakebites by spreading awareness, advocating for proper snakebite treatment protocols, and supporting organizations dedicated to snakebite research and education.

To learn more about the Asclepius Snakebite Foundation and how donations contribute to their mission, visit snakebitefoundation.org or contact [email protected]. 

Expert Availability: Dr. Nick Brandehoff is available for interviews, expert commentary, and feature stories to provide invaluable insights into the complexities of herpetology and snakebite treatment. April is the onset of snake season in the United States and there's an urgent need to elevate the conversation surrounding snakebite treatment and prevention.

Media Contact

Nick Brandehoff, MD, Asclepius Snakebite Foundation, 562-325-1664, [email protected], snakebitefoundation.org

SOURCE Asclepius Snakebite Foundation

Modal title

The Asclepius Snakebite Foundation is a 501(c)3 non-profit organization that aims to demystify snakebites and empower communities to take proactive measures.
The Asclepius Snakebite Foundation is a 501(c)3 non-profit organization that aims to demystify snakebites and empower communities to take proactive measures.
The Asclepius Snakebite Foundation is a 501(c)3 non-profit organization that aims to demystify snakebites and empower communities to take proactive measures.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.